Ravi K Amaravadi Selected Research

talazoparib

1/2020

Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ravi K Amaravadi Research Topics

Disease

63	Neoplasms (Cancer) 01/2024 - 02/2007
54	Melanoma (Melanoma, Malignant) 01/2024 - 05/2007
5	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2013
4	COVID-19 02/2024 - 01/2021
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 11/2017
3	Carcinogenesis 11/2020 - 01/2015
3	Inflammation (Inflammations) 03/2019 - 01/2015
3	Colonic Neoplasms (Colon Cancer) 01/2017 - 07/2007
3	Hypoxia (Hypoxemia) 01/2017 - 06/2013
3	Lymphoma (Lymphomas) 11/2015 - 02/2007
2	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2017
2	Colitis 01/2022 - 01/2021
2	Weight Loss (Weight Reduction) 01/2022 - 08/2014
2	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 01/2017
2	Adenocarcinoma 01/2020 - 11/2016
2	Toxic Optic Neuropathy 03/2019 - 10/2014
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 01/2017
2	Pancreatitis 01/2018 - 04/2002
2	Necrosis 01/2017 - 12/2007
2	Disease Progression 12/2016 - 07/2015
1	Infections 01/2021
1	Pathologic Complete Response 08/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 11/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019
1	Exanthema (Rash) 01/2018

Drug/Important Bio-Agent (IBA)

25	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2024 - 05/2011
9	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 05/2013
8	Chloroquine (Aralen)FDA LinkGeneric 02/2024 - 02/2007
8	VemurafenibIBA 01/2018 - 02/2012
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2013
5	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2016
5	Lys01IBA 11/2019 - 05/2012
4	dabrafenibIBA 01/2022 - 09/2013
4	trametinibIBA 01/2022 - 09/2013
4	Temozolomide (Temodar)FDA LinkGeneric 08/2014 - 12/2009
4	Sorafenib (BAY 43-9006)FDA Link 12/2012 - 03/2008
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2017
3	IpilimumabIBA 01/2022 - 01/2019
3	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 05/2012
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 08/2014
3	Small Interfering RNA (siRNA)IBA 01/2017 - 02/2007
2	pembrolizumabIBA 01/2024 - 01/2017
2	AntigensIBA 10/2022 - 01/2020
2	Peptides (Polypeptides)IBA 10/2022 - 01/2015
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2019
2	SteroidsIBA 01/2022 - 01/2021
2	Mitogen-Activated Protein KinasesIBA 11/2021 - 04/2015
2	Gemcitabine FDA Link 01/2020 - 07/2019
2	130-nm albumin-bound paclitaxelIBA 01/2020 - 07/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 03/2008
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2019 - 03/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2013
2	CateninsIBA 11/2017 - 12/2015
2	Estrogen ReceptorsIBA 01/2017 - 02/2007
2	Drug CombinationsIBA 01/2017 - 01/2017
2	LigandsIBA 12/2016 - 01/2015
2	birinapantIBA 11/2015 - 04/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015 - 04/2015
2	Bevacizumab (Avastin)FDA Link 08/2015 - 06/2013
1	EnzymesIBA 01/2023
1	eliglustatIBA 01/2023
1	Oxidants (Oxidizing Agents)IBA 10/2022
1	Peroxynitrous Acid (Peroxynitrite)IBA 10/2022
1	EpitopesIBA 10/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	regorafenibIBA 01/2022
1	entinostat (MS 275)IBA 01/2022
1	IronIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 08/2020
1	SAR405IBA 01/2020
1	palmitoyl-protein thioesteraseIBA 01/2020
1	rucaparibIBA 01/2020
1	olaparibIBA 01/2020
1	niraparibIBA 01/2020
1	talazoparibIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Poly Adenosine Diphosphate RiboseIBA 01/2020
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Apoptosis Regulatory ProteinsIBA 01/2020
1	Retinaldehyde (Retinal)IBA 03/2019
1	Everolimus FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	Interleukin-15 (Interleukin 15)IBA 01/2019
1	Fc Receptors (Fc Receptor)IBA 01/2019
1	MTOR InhibitorsIBA 01/2019
1	alpha-2'-deoxythioguanosineIBA 10/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2018
1	NucleosidesIBA 10/2018
1	Monoclonal AntibodiesIBA 01/2018

Therapy/Procedure

50	Therapeutics 01/2023 - 02/2007
12	Immunotherapy 01/2023 - 01/2018
11	Drug Therapy (Chemotherapy) 01/2023 - 02/2007
2	Radiotherapy 01/2021 - 08/2014
1	Mohs Surgery (Mohs' Micrographic Surgery) 10/2021